Immediate Impact
3 by Nobel laureates 6 from Science/Nature 80 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of Andy Blake-Haskins being referenced
A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andy Blake-Haskins | 368 | 126 | 14 | 194 | 13 | 408 | |
| Jim Vasselli | 355 | 121 | 16 | 198 | 9 | 396 | |
| Maria Anderson | 344 | 113 | 55 | 174 | 10 | 418 | |
| T Mørk | 176 | 66 | 30 | 82 | 12 | 339 | |
| Xianfa Wang | 253 | 180 | 11 | 63 | 13 | 371 | |
| Amy Sullivan | 253 | 158 | 9 | 123 | 16 | 373 | |
| Romany Johnpulle | 342 | 105 | 6 | 122 | 10 | 430 | |
| Jun Liang Teh | 256 | 180 | 10 | 132 | 17 | 446 | |
| Philip He | 271 | 104 | 7 | 81 | 19 | 440 | |
| Eriko Murakami | 399 | 190 | 12 | 71 | 15 | 447 | |
| Idoia Morilla | 339 | 122 | 20 | 172 | 17 | 435 |
All Works
Loading papers...